Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS
about
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will playRecent advances in the application of metabolomics to Alzheimer's DiseaseDefects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's diseaseWhy looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis.Proton MRS in mild cognitive impairment.Magnetic resonance spectroscopy in Alzheimer's disease.A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 miceMagnetic resonance spectroscopy in common dementiasCerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia.Advances in high-field magnetic resonance spectroscopy in Alzheimer's diseaseWhite matter hyperintensities and geriatric syndrome: An important role of arterial stiffness.Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysisOther magnetic resonance imaging techniques.Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD.Attitudes of the German general population toward early diagnosis of dementia--results of a representative telephone survey.CSF and brain structural imaging markers of the Alzheimer's pathological cascade.A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study.Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment.A summary risk score for the prediction of Alzheimer disease in elderly personsMRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's diseaseVascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study.Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's diseaseSleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC).Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.Thrombogenic microvesicles and white matter hyperintensities in postmenopausal womenMRI and MRS predictors of mild cognitive impairment in a population-based sample.Classification and epidemiology of MCI.Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction.White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.Metabolic status of CSF distinguishes rats with tauopathy from controls.Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy.The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.
P2860
Q24594531-71B2E18D-C934-4378-9B23-17BED7FAD8DCQ26828606-021AEDA0-8FDC-4BA2-B80C-D2C61BAEB484Q27307877-6C163E2B-6D8D-4C67-B1A8-3793FBDD3F43Q27692592-26A2056E-A393-4ABB-9DF3-3330464F307EQ30606675-E9C93E0E-8FF7-4430-9772-9966E6AF9DDAQ30630699-68F5EB86-5C2F-4656-8FE1-A5285EF51331Q30635401-1BBCBB81-5A48-4111-989D-35799F4F72D9Q30660402-7AAC14D8-76C9-4B39-BD9C-AF8CA3EE3710Q30733242-C909455D-20B3-40B2-9B8E-F9628EE359C8Q30770751-DCD0610F-2C55-4094-B929-7C324B01D364Q31032253-23E11A39-B532-472F-8755-8D675B2FBF31Q31096423-024AC957-7FDA-4F0B-BE33-F1665489B0E2Q33641052-E7EEF737-126C-4896-B45A-9502A58E5B7BQ33993466-C9B82262-E7B2-438A-93C9-5BEC2F364396Q34149357-864DDF74-D15E-4A40-95D7-5E0096FA3F83Q34380374-FBCE03A0-F95B-46F9-B344-9A55C4302067Q34500715-B7D5A2A7-6F7E-4AFA-BD92-0234A52E591FQ34531387-CE865A19-C964-4689-A134-0D1A0BB6B4DFQ34632216-BB430D00-807A-46A2-8228-29BD6705AC4CQ34733398-40163C5E-FD83-42BD-91CF-F35CB2EDAC91Q34747831-ACE3114C-36F1-4F22-BC59-970F7E91B0D8Q34964670-E48F6296-8906-4340-8D0D-A424D20D8AC7Q35019559-344A8A0F-81DB-463C-9666-00510DD73196Q35048396-EF97015E-8A68-4E41-9C63-77BA4CD1BBB9Q35218921-E2F93B6E-E41D-4AEF-B12E-16BD9F4325EDQ35319467-9D3759BD-46CD-4710-B6FE-9CBDC00400FEQ35833686-0EE0B667-2472-4D20-86D3-4099DC724CAAQ36077696-5F94BF61-5FD7-4A09-9A21-2A1A9CB33E28Q36093127-BF575122-8799-4101-B3C5-0E0AF5300B4DQ36841519-D98E990E-AF9C-4536-AE4B-5B7417798BEBQ37163305-80BF5AA0-0867-4565-BED2-BCB0949AA2AEQ37290686-021082DD-21CD-43C2-98A5-CE729281D787Q38190687-7E471DE9-B1DD-43E4-B381-8D781AA4C7BFQ38664709-48935B41-1D99-48BC-B3D9-4C34D72C6E8CQ40457900-044625BA-D712-4D6F-8D32-5DDDBD0090B4Q41690749-8C04ECC6-7272-421A-AB2C-B732E4CBFE61Q41982613-FC7C826E-3F3E-4D82-996F-F85696C2A9C2Q44937365-76529634-BA23-4815-B605-F571AA86B0BAQ47099532-A5758B8C-1FA7-4B60-A7B7-D1A72235755BQ47136067-B69639E2-0C10-4B9F-884B-531BB141AA27
P2860
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Risk of dementia in MCI: combi ...... se, volumetric MRI, and 1H MRS
@ast
Risk of dementia in MCI: combi ...... se, volumetric MRI, and 1H MRS
@en
type
label
Risk of dementia in MCI: combi ...... se, volumetric MRI, and 1H MRS
@ast
Risk of dementia in MCI: combi ...... se, volumetric MRI, and 1H MRS
@en
prefLabel
Risk of dementia in MCI: combi ...... se, volumetric MRI, and 1H MRS
@ast
Risk of dementia in MCI: combi ...... se, volumetric MRI, and 1H MRS
@en
P2093
P2860
P50
P1433
P1476
Risk of dementia in MCI: combi ...... se, volumetric MRI, and 1H MRS
@en
P2093
D S Knopman
J L Whitwell
M M Shiung
P C O'Brien
R C Petersen
S A Przybelski
S D Weigand
P2860
P304
P356
10.1212/WNL.0B013E3181A2E864
P407
P577
2009-04-01T00:00:00Z